Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biostem Technologies Inc (BSEM)

Biostem Technologies Inc (BSEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 264,798
  • Shares Outstanding, K 16,654
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta -0.53
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 23.12
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.32 on 11/12/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.8000 +32.42%
on 12/30/24
16.2500 -3.84%
on 01/21/25
+1.1860 (+8.21%)
since 12/20/24
3-Month
11.2500 +38.90%
on 10/22/24
28.2565 -44.70%
on 11/12/24
+3.9560 (+33.90%)
since 10/21/24
52-Week
4.4100 +254.33%
on 01/29/24
28.2565 -44.70%
on 11/12/24
+9.1260 (+140.40%)
since 01/19/24

Most Recent Stories

More News
BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million

BSEM : 15.6260 (-1.72%)
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®

BSEM : 15.6260 (-1.72%)
BioStem Technologies CEO to Present at Biotech Showcase 2025

BSEM : 15.6260 (-1.72%)
BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts

BSEM : 15.6260 (-1.72%)
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

BSEM : 15.6260 (-1.72%)
Small and Micro-Cap Movers: Your Daily Digest of High-Impact News From High-Growth Companies Rising in Popularity

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in...

BCHT : 0.5410 (-1.64%)
MNTS : 8.31 (+25.15%)
ONTF : 6.51 (+1.09%)
RELL : 13.73 (+1.25%)
BSEM : 15.6260 (-1.72%)
MOGO : 1.2995 (+3.96%)
TRAK : 21.81 (+1.77%)
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million

BSEM : 15.6260 (-1.72%)
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

BSEM : 15.6260 (-1.72%)
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

BSEM : 15.6260 (-1.72%)
BioStem Technologies to Present at the LD Micro Main Event XVII on Wednesday, October 30, 2024, at 9:30 AM PT

Presentation to be webcast, with management participating in 1-on-1 meetings at the Luxe Sunset Boulevard Hotel in Los AngelesPompano Beach, Florida--(Newsfile Corp. - October 23, 2024) - BioStem Technologies,...

BSEM : 15.6260 (-1.72%)

Business Summary

BioStem Technologies Inc. is a regenerative medicine company. It focused on the development, manufacture and commercialization of placental derived biologics. The company's portfolio of brands includes VENDAJE(R), VENDAJE AC(R) and VENDAJE OPTIC(R). BioStem Technologies Inc. is based in POMPANO BEACH,...

See More

Key Turning Points

3rd Resistance Point 16.9533
2nd Resistance Point 16.5267
1st Resistance Point 16.2133
Last Price 15.6260
1st Support Level 15.4733
2nd Support Level 15.0467
3rd Support Level 14.7333

See More

52-Week High 28.2565
Fibonacci 61.8% 19.1471
Fibonacci 50% 16.3333
Last Price 15.6260
Fibonacci 38.2% 13.5194
52-Week Low 4.4100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar